DEF 14A

Company

aTYR PHARMA INC

Filed

March 26, 2026

Period of Report

March 26, 2026

Accession Number

0001339970-26-000021

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →